- Anterior Chamber Phakic IOL
- Anterior chamber iris-fixated
- Anterior chamber angle-supported
- Posterior
Phakic Intraocular Lenses Market size was valued at USD 386.3 million in 2023 and is poised to grow at a CAGR of 9.5% over the forecast years 2024 - 2030. Phakic intraocular lenses are synthetic lenses made of plastic or silicone, that are implanted over natural lenses inside eyes to rectify the ametropic condition. Phakic lenses are utilized to correct refractive errors, errors in the eye's focusing power. It has advantages over laser therapy such as a wide range of corrections, reversibility, fewer complications, outperforming other therapies in terms of best spectacle-corrected visual acuity (BSCVA), and preservation of natural lens.
An increasing number of myopic patients, rise in the prevalence of diabetes, grow in the number old age people with developing eye disorders, increasing screen time from the usage of gadgets, advancements in healthcare in developed countries, and increasing acceptance of the therapy are the main driving forces of the market. The phakic intraocular lens remains a main trend among the young generation in developed countries who prefer permanent lenses instead of wearing specs. Countries such as China, India, Japan, and South Korea prevail in the number of myopes consisting up to 80% of the population being myopic which is a main opportunity for the key players in the market as research is being done continuously to reduce the cost of implantation, thus successfully entering the developing countries. The biggest restraint for this market to expand is the cost of the implantation, the lack of reimbursement policies for the patients undergoing surgery, and the advancements in alternative options such as glasses, lenses, LASIK therapy, and photorefractive keratectomy.
Study Period
2024-2030Base Year
2023CAGR
9.5%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Major brands are launching new and improved products for the treatment of ametropic conditions. The increasing demand and preference from the youth generation, adaptation from old generation and reduction of the cost of implantation will help to expand the market. The increasing prevalence of diabetes is also a main driving factor of ametropic conditions which in turn a tapping opportunity for implantation. The expected growth of myopes is around 50% of the world population by 2050. Moreover, development and launch of newer products by the companies significantly enhances the revenue of phakic intraocular lens market over the forecast timeframe.
By Product
By Coundition
By End User
STAR SURGICALS, J&J, Verathon are the key market players in the global Phakic Ocular lens market.
North America dominates the Phakic Intraocular Lenses Market with the largest revenue share
The biggest restraint for this market to expand is the cost of the implantation, lack of reimbursement policies for the patient’s undergoing surgery and the advancements in alternative options such as glasses, lenses, LASIK therapy, and photorefractive keratectomy.
The Phakic Intraocular Lens Market size was estimated at USD 386.3 million in 2023 and is expected to grow at a CAGR of 9.5% over the forecast years 2024 - 2030.
1.Executive Summary |
2.Global Phakic Intraocular Lenses Market Introduction |
2.1.Global Phakic Intraocular Lenses Market - Taxonomy |
2.2.Global Phakic Intraocular Lenses Market - Definitions |
2.2.1.Product |
2.2.2.Coundition |
2.2.3.End User |
2.2.4.Region |
3.Global Phakic Intraocular Lenses Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Phakic Intraocular Lenses Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Phakic Intraocular Lenses Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Anterior Chamber Phakic IOL |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Posterior |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Phakic Intraocular Lenses Market By Coundition, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Myopia |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Hyperopia |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Astigmatism |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Phakic Intraocular Lenses Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Ophthalmology Clinics |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Ambulatory Surgical Centres |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Phakic Intraocular Lenses Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Phakic Intraocular Lenses Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Anterior Chamber Phakic IOL |
9.1.2.Posterior |
9.2. Coundition Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Myopia |
9.2.2.Hyperopia |
9.2.3.Astigmatism |
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Ophthalmology Clinics |
9.3.3.Ambulatory Surgical Centres |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Phakic Intraocular Lenses Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Anterior Chamber Phakic IOL |
10.1.2.Posterior |
10.2. Coundition Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Myopia |
10.2.2.Hyperopia |
10.2.3.Astigmatism |
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Ophthalmology Clinics |
10.3.3.Ambulatory Surgical Centres |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Phakic Intraocular Lenses Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Anterior Chamber Phakic IOL |
11.1.2.Posterior |
11.2. Coundition Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Myopia |
11.2.2.Hyperopia |
11.2.3.Astigmatism |
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Ophthalmology Clinics |
11.3.3.Ambulatory Surgical Centres |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Phakic Intraocular Lenses Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Anterior Chamber Phakic IOL |
12.1.2.Posterior |
12.2. Coundition Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Myopia |
12.2.2.Hyperopia |
12.2.3.Astigmatism |
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Ophthalmology Clinics |
12.3.3.Ambulatory Surgical Centres |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Phakic Intraocular Lenses Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Anterior Chamber Phakic IOL |
13.1.2.Posterior |
13.2. Coundition Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Myopia |
13.2.2.Hyperopia |
13.2.3.Astigmatism |
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Ophthalmology Clinics |
13.3.3.Ambulatory Surgical Centres |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Ambu |
14.2.2.Aurolab |
14.2.3.Boston Scientific |
14.2.4.Care Group |
14.2.5.Duomed |
14.2.6.HOYA Corporation |
14.2.7.Johnson & Johnson |
14.2.8.Neoscope Inc |
14.2.9.Olympus |
14.2.10.Omni Lens Pvt Ltd |
14.2.11.Ophtec BV/Abbott |
14.2.12.PENTAX Medical |
14.2.13.Rayner Surgical Group Limited |
14.2.14.STAAR SURGICAL |
14.2.15.USIOL Inc. |
14.2.16.Verathon Inc |
14.2.17.Zeiss |
15. Research Methodology |
16. Appendix and Abbreviations |